Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].

Creinin, Mitchell D; Schreiber, Courtney A; Turok, David K; Cwiak, Carrie; Chen, Beatrice A; Olariu, Andrea I

Creinin, Mitchell D; Schreiber, Courtney A; Turok, David K; Cwiak, Carrie; Chen, Beatrice A; Olariu, Andrea I.

Afiliación

Creinin MD; Division of Family Planning, Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA.
Schreiber CA; Division of Family Planning, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA.
Turok DK; Division of Family Planning, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT.
Cwiak C; Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA.
Chen BA; Division of Gynecologic Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, PA.
Olariu AI; Medicines 360, San Francisco, CA.

Am J Obstet Gynecol ; 229(3): 358, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37495438

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Am J Obstet Gynecol Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Am J Obstet Gynecol Año: 2023 Tipo del documento: Article País de afiliación: Canadá